All Pharma News
Seres Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
28 Mar 2024
Share Share
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
05 Mar 2024
Share Share
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results
BUSINESSWIRE
28 Feb 2024
Share Share
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
BUSINESSWIRE
27 Feb 2024
Share Share
Seres Therapeutics Announces the Appointment of Marella Thorell as CFO

Seres Therapeutics Announces the Appointment of Marella Thorell as CFO
BUSINESSWIRE
26 Feb 2024
Share Share
Seres Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
17 Jan 2024
Share Share
Seres to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Seres to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BUSINESSWIRE
04 Jan 2024
Share Share
Seres Therapeutics Announces Presentation of Safety Data for SER-155

Seres Therapeutics Announces Presentation of Safety Data for SER-155
BUSINESSWIRE
07 Dec 2023
Share Share
Seres to Participate in the Piper Sandler 35th Annual Healthcare Conference

Seres to Participate in the Piper Sandler 35th Annual Healthcare Conference
BUSINESSWIRE
28 Nov 2023
Share Share
Seres slims R&D, staff to focus on approved microbiome drug

Seres slims R&D, staff to focus on approved microbiome drug
Annalee Armstrong FIERCE BIOTECH
02 Nov 2023
Share Share